Leucostim (rhG-CSF biosimilar) / Hikma, Dong-A, Biocad  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Leucostim (rhG-CSF biosimilar) / Biocad, Hikma, Dong-A
NCT01820715: A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain

Completed
1
31
RoW
600㎍ of DA-3030 Injection, Placebo
Dong-A Pharmaceutical Co., Ltd.
Diabetic Neuropathy
04/13
 
NCT02725086: Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers

Completed
1
56
RoW
Leucostim®, DA-3030, Neupogen®
Dong-A ST Co., Ltd.
Healthy
04/16
05/16
NCT02762799: Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

Completed
1
60
NA
Leucostim®, filgrastim, Neupogen®
Biocad
Leucocytosis
11/16
11/16

Download Options